US20030113271A1
(en)
*
|
1997-01-29 |
2003-06-19 |
University Technology Corporation |
Formulations for pulmonary delivery
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US20020055702A1
(en)
*
|
1998-02-10 |
2002-05-09 |
Anthony Atala |
Ultrasound-mediated drug delivery
|
ATE537811T1
(de)
†
|
1999-02-08 |
2012-01-15 |
Intarcia Therapeutics Inc |
Stabile nicht wässerige einphasige visköse vehikel und formulierungen die diese vehikel verwenden
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
US7919119B2
(en)
*
|
1999-05-27 |
2011-04-05 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US6610317B2
(en)
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
US6254852B1
(en)
*
|
1999-07-16 |
2001-07-03 |
Dupont Pharmaceuticals Company |
Porous inorganic targeted ultrasound contrast agents
|
WO2001010446A2
(en)
*
|
1999-08-09 |
2001-02-15 |
Pharmacia & Upjohn S.P.A. |
Formulations for parenteral use of estramustine phosphate and albumin
|
WO2001012069A1
(en)
*
|
1999-08-13 |
2001-02-22 |
Point Biomedical Corporation |
Hollow microspheres with controlled fragility for medical use
|
GB9921954D0
(en)
*
|
1999-09-16 |
1999-11-17 |
Pharmacia & Upjohn Spa |
Formulations for parenteral use of estramustine phosphate with improved pharmacological properties
|
GB9921958D0
(en)
|
1999-09-16 |
1999-11-17 |
Pharmacia & Upjohn Spa |
Formulations for parenteral use of estramustine phosphate and sulfoalkylether-cyclodextrins
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
DE10024451A1
(de)
*
|
2000-05-18 |
2001-11-29 |
Asta Medica Ag |
Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
|
US6676963B1
(en)
*
|
2000-10-27 |
2004-01-13 |
Barnes-Jewish Hospital |
Ligand-targeted emulsions carrying bioactive agents
|
US7374782B2
(en)
|
2000-10-27 |
2008-05-20 |
Baxter International Inc. |
Production of microspheres
|
CA2359812C
(en)
*
|
2000-11-20 |
2004-02-10 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
|
US9700866B2
(en)
*
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US8235919B2
(en)
*
|
2001-01-12 |
2012-08-07 |
Celleration, Inc. |
Ultrasonic method and device for wound treatment
|
FR2823675B1
(fr)
*
|
2001-04-19 |
2004-03-12 |
Inst Nat Sante Rech Med |
Biomateriaux avec recouvrements bioactifs
|
US6849271B2
(en)
*
|
2001-04-27 |
2005-02-01 |
Verion, Inc. |
Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods
|
EP1408876A4
(en)
|
2001-06-22 |
2004-09-22 |
Durect Corp |
ZERO ORDER COAXIAL IMPLANTS WITH EXTENDED RELEASE
|
US6458769B1
(en)
*
|
2001-06-25 |
2002-10-01 |
Astrazeneca Ab |
Amorphous compound
|
WO2003015750A1
(en)
*
|
2001-08-16 |
2003-02-27 |
Baxter International, Inc. |
Propellant-based microparticle formulations
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
WO2003039514A1
(en)
*
|
2001-10-18 |
2003-05-15 |
Verion Inc. |
Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods
|
US20030109824A1
(en)
*
|
2001-11-07 |
2003-06-12 |
Microvena Corporation |
Distal protection device with local drug delivery to maintain patency
|
US20070196415A1
(en)
*
|
2002-11-14 |
2007-08-23 |
Guohua Chen |
Depot compositions with multiple drug release rate controls and uses thereof
|
BR0206987A
(pt)
*
|
2001-11-14 |
2004-02-10 |
Alza Corp |
Composições de depósito injetáveis por cateter e usos destes
|
EP1458360B1
(en)
|
2001-12-19 |
2011-05-11 |
Novartis AG |
Pulmonary delivery of aminoglycosides
|
US7923431B2
(en)
|
2001-12-21 |
2011-04-12 |
Ferrosan Medical Devices A/S |
Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
|
WO2003057949A1
(en)
*
|
2002-01-04 |
2003-07-17 |
Nuccon Technologies Inc. |
Preparation of nano-sized crystals
|
US7300670B2
(en)
*
|
2002-04-03 |
2007-11-27 |
Unilab Pharmatech, Ltd. |
Oral suspension formulation
|
US6835387B2
(en)
|
2002-06-11 |
2004-12-28 |
Scimed Life Systems, Inc. |
Sustained release of superoxide dismutase mimics from implantable or insertable medical devices
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
CN1668276A
(zh)
*
|
2002-07-31 |
2005-09-14 |
阿尔萨公司 |
可注射的储库组合物及其用途
|
DE60325742D1
(de)
*
|
2002-07-31 |
2009-02-26 |
Alza Corp |
Injizierbare multimodale polymere depotzusammensetzungen und ihre verwendungen
|
DE10244847A1
(de)
|
2002-09-20 |
2004-04-01 |
Ulrich Prof. Dr. Speck |
Medizinische Vorrichtung zur Arzneimittelabgabe
|
CA2498798A1
(en)
*
|
2002-09-20 |
2004-04-01 |
Alpharma, Inc. |
Sustained-release opioid formulations and methods of use
|
US7273889B2
(en)
*
|
2002-09-25 |
2007-09-25 |
Innovative Drug Delivery Systems, Inc. |
NMDA receptor antagonist formulation with reduced neurotoxicity
|
GB0224986D0
(en)
*
|
2002-10-28 |
2002-12-04 |
Smith & Nephew |
Apparatus
|
AU2003302906B2
(en)
*
|
2002-12-11 |
2009-04-02 |
Ferrosan Medical Devices A/S |
Gelatine-based materials as swabs
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
WO2004060903A2
(en)
*
|
2002-12-31 |
2004-07-22 |
Nektar Therapeutics |
Aerosolizable pharmaceutical formulation for fungal infection therapy
|
US7494544B2
(en)
*
|
2003-01-23 |
2009-02-24 |
Bj Services Company |
Polymer shell encapsulated gas as a cement expansion additive
|
US7543642B2
(en)
*
|
2003-01-24 |
2009-06-09 |
Halliburton Energy Services, Inc. |
Cement compositions containing flexible, compressible beads and methods of cementing in subterranean formations
|
US20050196439A1
(en)
*
|
2003-10-24 |
2005-09-08 |
J. Rettenmaier & Soehne Gmbh + Co. Kg |
Process for co-spray drying agents with dry silicified MCC
|
US11298453B2
(en)
|
2003-10-28 |
2022-04-12 |
Smith & Nephew Plc |
Apparatus and method for wound cleansing with actives
|
AR054637A1
(es)
*
|
2004-01-30 |
2007-07-11 |
Ferrosan As |
Aerosoles y composiciones hemostaticas
|
US7753894B2
(en)
|
2004-04-27 |
2010-07-13 |
Smith & Nephew Plc |
Wound cleansing apparatus with stress
|
GB0409446D0
(en)
|
2004-04-28 |
2004-06-02 |
Smith & Nephew |
Apparatus
|
US8529548B2
(en)
|
2004-04-27 |
2013-09-10 |
Smith & Nephew Plc |
Wound treatment apparatus and method
|
US10413644B2
(en)
|
2004-04-27 |
2019-09-17 |
Smith & Nephew Plc |
Wound treatment apparatus and method
|
KR20050104152A
(ko)
|
2004-04-28 |
2005-11-02 |
최승호 |
경구용 약물의 흡수를 증진하는 약제학적 조성물
|
US7399490B2
(en)
*
|
2004-05-17 |
2008-07-15 |
Lean For Life, Inc. |
Compositions containing a nopal cactus isolate and method for making same
|
US8021684B2
(en)
*
|
2004-07-09 |
2011-09-20 |
Ferrosan Medical Devices A/S |
Haemostatic composition comprising hyaluronic acid
|
BRPI0514753A
(pt)
*
|
2004-08-31 |
2008-06-24 |
Pfizer Prod Inc |
formas de dosagem farmacêutica compreendendo um medicamento de baixa solubilidade e um polìmero
|
US8750983B2
(en)
|
2004-09-20 |
2014-06-10 |
P Tech, Llc |
Therapeutic system
|
WO2006044996A2
(en)
*
|
2004-10-15 |
2006-04-27 |
The Trustees Of Columbia University In The City Of New York |
System and method for automated boundary detection of body structures
|
WO2006047660A2
(en)
*
|
2004-10-26 |
2006-05-04 |
The University Of North Carolina At Chapel Hill |
Methods of acoustic measurement and control of pharmaceutical sprays
|
US8165460B2
(en)
*
|
2004-10-26 |
2012-04-24 |
The University Of North Carolina At Chapel Hill |
Coated filament for evaporation/condensation aerosol generation of therapeutic agents and methods for using
|
JP4880615B2
(ja)
|
2004-12-23 |
2012-02-22 |
ダウ・コーニング・コーポレイション |
架橋可能なサッカライド−シロキサン組成物、ならびにこれから形成された網目状構造体、コーティング、および製品
|
US20060142234A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
US10687785B2
(en)
|
2005-05-12 |
2020-06-23 |
The Trustees Of Columbia Univeristy In The City Of New York |
System and method for electromechanical activation of arrhythmias
|
JP5122444B2
(ja)
*
|
2005-05-23 |
2013-01-16 |
ダウ・コーニング・コーポレイション |
サッカリド−シロキサンコポリマーを含むパーソナルケア組成物
|
CN102418279B
(zh)
*
|
2005-05-23 |
2014-12-17 |
陶氏康宁公司 |
含糖-硅氧烷共聚物的表面处理组合物
|
KR101643416B1
(ko)
*
|
2005-08-31 |
2016-07-27 |
아브락시스 바이오사이언스, 엘엘씨 |
증가된 안정성을 가진 수 난용성 약물의 조성물 및 제조방법
|
CA2620585C
(en)
*
|
2005-08-31 |
2015-04-28 |
Abraxis Bioscience, Llc |
Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
|
AU2006287460A1
(en)
|
2005-09-07 |
2007-03-15 |
Tyco Healthcare Group Lp |
Wound dressing with vacuum reservoir
|
EP1937151A4
(en)
*
|
2005-09-19 |
2011-07-06 |
Univ Columbia |
SYSTEMS AND METHOD FOR OPENING THE BLOOD-BRAIN BARRIER OF A PERSON WITH ULTRASOUND
|
CN101309709A
(zh)
*
|
2005-09-21 |
2008-11-19 |
苏尔莫迪克斯公司 |
包含天然生物可降解的多糖的涂层和物品
|
WO2007035865A1
(en)
*
|
2005-09-21 |
2007-03-29 |
Surmodics, Inc. |
Coatings and articles including natural biodegradable polysaccharides
|
JP2007089086A
(ja)
*
|
2005-09-26 |
2007-04-05 |
Sony Ericsson Mobilecommunications Japan Inc |
携帯情報端末及び画像管理プログラム
|
US20070141106A1
(en)
*
|
2005-10-19 |
2007-06-21 |
Bonutti Peter M |
Drug eluting implant
|
US8882747B2
(en)
*
|
2005-11-09 |
2014-11-11 |
The Invention Science Fund I, Llc |
Substance delivery system
|
US8226975B2
(en)
|
2005-12-08 |
2012-07-24 |
Insmed Incorporated |
Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
|
WO2007067761A2
(en)
*
|
2005-12-08 |
2007-06-14 |
Tyco Healthcare Group Lp |
Viscosity-reduced sprayable compositions
|
AU2006321721B2
(en)
|
2005-12-08 |
2012-07-05 |
Covidien Lp |
Biocompatible surgical compositons
|
WO2007067764A2
(en)
*
|
2005-12-08 |
2007-06-14 |
Tyco Healthcare Group Lp |
Biocompatible surgical compositions
|
US20090221916A1
(en)
*
|
2005-12-09 |
2009-09-03 |
The Trustees Of Columbia University In The City Of New York |
Systems and Methods for Elastography Imaging
|
CN101365469A
(zh)
*
|
2005-12-13 |
2009-02-11 |
哈克尼斯药品公司 |
使用肠抑素治疗肥胖的方法
|
US20070149457A1
(en)
*
|
2005-12-13 |
2007-06-28 |
Byron Rubin |
Stable solid forms of enterostatin
|
AR054215A1
(es)
|
2006-01-20 |
2007-06-13 |
Eriochem Sa |
Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
|
US20090130212A1
(en)
*
|
2006-05-15 |
2009-05-21 |
Physical Pharmaceutica, Llc |
Composition and improved method for preparation of small particles
|
US8968773B2
(en)
*
|
2006-05-23 |
2015-03-03 |
Dow Corning Corporation |
Silicone film former for delivery of actives
|
CN101453982B
(zh)
|
2006-05-30 |
2011-05-04 |
精达制药公司 |
两件式内部通道渗透递送系统流动调节器
|
US7803148B2
(en)
|
2006-06-09 |
2010-09-28 |
Neurosystec Corporation |
Flow-induced delivery from a drug mass
|
CA2657578A1
(en)
*
|
2006-07-11 |
2008-01-17 |
Harkness Pharmaceuticals, Inc. |
Methods of treating obesity using satiety factors
|
WO2008021133A2
(en)
|
2006-08-09 |
2008-02-21 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies
|
CA2661352A1
(en)
*
|
2006-08-22 |
2008-02-28 |
Donald N. Schwartz |
Ultrasonic treatment of glaucoma
|
US8043235B2
(en)
*
|
2006-08-22 |
2011-10-25 |
Schwartz Donald N |
Ultrasonic treatment of glaucoma
|
TW200817055A
(en)
*
|
2006-10-04 |
2008-04-16 |
Univ Nat Cheng Kung |
Disinfection method for biomaterial
|
US10232064B2
(en)
|
2006-10-04 |
2019-03-19 |
National Cheng Kung University |
Method for sterilizing biological materials
|
US8414910B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US8414526B2
(en)
*
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
|
US8998846B2
(en)
|
2006-11-20 |
2015-04-07 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
US8414525B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US9737640B2
(en)
|
2006-11-20 |
2017-08-22 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US8425459B2
(en)
|
2006-11-20 |
2013-04-23 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
|
US20080276935A1
(en)
|
2006-11-20 |
2008-11-13 |
Lixiao Wang |
Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
|
US8414909B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US8430055B2
(en)
*
|
2008-08-29 |
2013-04-30 |
Lutonix, Inc. |
Methods and apparatuses for coating balloon catheters
|
US9700704B2
(en)
|
2006-11-20 |
2017-07-11 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
KR100816065B1
(ko)
*
|
2006-11-27 |
2008-03-24 |
동국제약 주식회사 |
초기 방출억제 특성이 우수한 서방출성 마이크로캡슐의제조방법 및 이에 의해 제조되는 마이크로캡슐
|
US8491521B2
(en)
|
2007-01-04 |
2013-07-23 |
Celleration, Inc. |
Removable multi-channel applicator nozzle
|
US8741316B2
(en)
*
|
2007-03-12 |
2014-06-03 |
Board Of Regents, The University Of Texas System |
Highly porous, recognitive polymer systems
|
WO2008112826A1
(en)
*
|
2007-03-12 |
2008-09-18 |
Board Of Regents, The University Of Texas System |
Method and process for the production of multi-coated recognitive and releasing systems
|
US8821899B2
(en)
*
|
2007-03-12 |
2014-09-02 |
Board Of Regents, The University Of Texas System |
Method and process for the production of multi-coated recognitive and releasing systems
|
US8771713B2
(en)
*
|
2007-03-12 |
2014-07-08 |
Board Of Regents, The University Of Texas System |
Method and process for the production of multi-coated recognitive and releasing systems
|
US20080262512A1
(en)
*
|
2007-04-02 |
2008-10-23 |
Doheny Eye Institute |
Thrombolysis In Retinal Vessels With Ultrasound
|
EP2157967B1
(en)
|
2007-04-23 |
2013-01-16 |
Intarcia Therapeutics, Inc |
Suspension formulations of insulinotropic peptides and uses thereof
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
JP2010528006A
(ja)
*
|
2007-05-18 |
2010-08-19 |
バレント・バイオサイエンシーズ・コーポレイション |
桂皮アルデヒド製剤および使用方法
|
CA2688506A1
(en)
*
|
2007-05-31 |
2008-12-04 |
Biocrates Life Sciences Ag |
Inflammation and oxidative stress level assay
|
US20100297249A1
(en)
*
|
2007-07-05 |
2010-11-25 |
North-West University |
Enhancement of the efficacy of therapeutic proteins
|
WO2009020994A2
(en)
*
|
2007-08-06 |
2009-02-12 |
Doheny Eye Institute |
Ultrasound and microbubbles in ocular diagnostics and therapies
|
AR063111A1
(es)
|
2007-10-03 |
2008-12-30 |
Eriochem Sa |
Una formulacion farmaceutica de taxano
|
JP5419704B2
(ja)
*
|
2007-11-07 |
2014-02-19 |
株式会社カネカ |
固体脂を使ったマイクロカプセルの製造方法
|
US9242295B2
(en)
|
2007-12-21 |
2016-01-26 |
The Univeristy Of Texas At Arlington |
Bulk nanocomposite magnets and methods of making bulk nanocomposite magnets
|
US20100054981A1
(en)
|
2007-12-21 |
2010-03-04 |
Board Of Regents, The University Of Texas System |
Magnetic nanoparticles, bulk nanocomposite magnets, and production thereof
|
US20090177123A1
(en)
*
|
2007-12-28 |
2009-07-09 |
Celleration, Inc. |
Methods for treating inflammatory disorders
|
IL188647A0
(en)
*
|
2008-01-08 |
2008-11-03 |
Orina Gribova |
Adaptable structured drug and supplements administration system (for oral and/or transdermal applications)
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
US7662413B2
(en)
*
|
2008-02-27 |
2010-02-16 |
Chung Shan Medical University |
Extracts of sacred water lotus for the treatment of cancer
|
US8642831B2
(en)
*
|
2008-02-29 |
2014-02-04 |
Ferrosan Medical Devices A/S |
Device for promotion of hemostasis and/or wound healing
|
WO2011035312A1
(en)
|
2009-09-21 |
2011-03-24 |
The Trustees Of Culumbia University In The City Of New York |
Systems and methods for opening of a tissue barrier
|
US8936811B2
(en)
*
|
2008-05-07 |
2015-01-20 |
Surmodics, Inc. |
Device coated with glycogen particles comprising nucleic acid complexes
|
CA2723588A1
(en)
|
2008-05-12 |
2009-11-19 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated uses
|
US9877973B2
(en)
|
2008-05-12 |
2018-01-30 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
US9095404B2
(en)
|
2008-05-12 |
2015-08-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
US10064819B2
(en)
|
2008-05-12 |
2018-09-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
EP2299894B1
(en)
|
2008-06-18 |
2020-09-02 |
Sarcos LC |
Transparent endoscope head defining a focal length
|
EP2307021A4
(en)
*
|
2008-06-19 |
2011-08-10 |
Neurosystec Corp |
FORMULATIONS
|
AU2009270415B2
(en)
*
|
2008-07-18 |
2015-09-17 |
Nntt Tech Inc |
Articles of manufacture releasing an active ingredient
|
WO2010014792A2
(en)
|
2008-07-30 |
2010-02-04 |
Sterling Lc |
Method and device for incremental wavelength variation to analyze tissue
|
WO2010014977A1
(en)
|
2008-08-01 |
2010-02-04 |
The Trustees Of Columbia University In The City Of New York |
Systems and methods for matching and imaging tissue characteristics
|
WO2010030819A1
(en)
|
2008-09-10 |
2010-03-18 |
The Trustees Of Columbia University In The City Of New York |
Systems and methods for opening a tissue
|
US9060704B2
(en)
*
|
2008-11-04 |
2015-06-23 |
Sarcos Lc |
Method and device for wavelength shifted imaging
|
NZ596515A
(en)
|
2009-05-29 |
2014-03-28 |
Cydex Pharmaceuticals Inc |
Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same
|
US11020363B2
(en)
|
2009-05-29 |
2021-06-01 |
Cydex Pharmaceuticals, Inc. |
Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
|
MX340134B
(es)
|
2009-07-09 |
2016-06-28 |
Oshadi Drug Administration Ltd |
Composiciones portadoras de matriz, métodos y usos.
|
FR2948024B1
(fr)
*
|
2009-07-17 |
2020-01-10 |
Centre National De La Recherche Scientifique - Cnrs - |
Emulsion activable par ultrasons et son procede de fabrication.
|
US10058837B2
(en)
|
2009-08-28 |
2018-08-28 |
The Trustees Of Columbia University In The City Of New York |
Systems, methods, and devices for production of gas-filled microbubbles
|
CN104323981B
(zh)
|
2009-09-28 |
2019-03-12 |
精达制药公司 |
基本稳态药物递送的快速建立和/或终止
|
WO2011041720A2
(en)
|
2009-10-01 |
2011-04-07 |
Jacobsen Stephen C |
Method and apparatus for manipulating movement of a micro-catheter
|
US8717428B2
(en)
*
|
2009-10-01 |
2014-05-06 |
Raytheon Company |
Light diffusion apparatus
|
US8828028B2
(en)
|
2009-11-03 |
2014-09-09 |
Raytheon Company |
Suture device and method for closing a planar opening
|
US10010709B2
(en)
*
|
2009-12-16 |
2018-07-03 |
The Trustees Of Columbia University In The City Of New York |
Composition for on-demand ultrasound-triggered drug delivery
|
JP2013515005A
(ja)
*
|
2009-12-17 |
2013-05-02 |
ネイティビス, インコーポレイテッド |
水性組成物および方法
|
CN103080288B
(zh)
*
|
2010-04-12 |
2016-04-27 |
克罗玛夫洛技术公司 |
用于使溶剂基涂料着色的低voc溶剂型颜料分散体组合物
|
EP2609138B1
(en)
|
2010-08-23 |
2017-05-17 |
Dow Corning Corporation |
Saccharide siloxanes stable in aqueous environments and methods for the preparation and use of such saccharide siloxanes
|
JP2014504260A
(ja)
*
|
2010-10-15 |
2014-02-20 |
グラクソ グループ リミテッド |
集合ナノ粒子状薬物製剤、その製造及び使用
|
US8901092B2
(en)
|
2010-12-29 |
2014-12-02 |
Surmodics, Inc. |
Functionalized polysaccharides for active agent delivery
|
CA2823628A1
(en)
|
2011-01-05 |
2012-07-12 |
Hospira, Inc. |
Spray drying vancomycin
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
US9579283B2
(en)
|
2011-04-28 |
2017-02-28 |
Stc.Unm |
Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
|
WO2012162664A1
(en)
|
2011-05-26 |
2012-11-29 |
The Trustees Of Columbia University In The City Of New York |
Systems and methods for opening of a tissue barrier in primates
|
EA201490220A1
(ru)
*
|
2011-07-15 |
2014-07-30 |
Фемалон С.П.Р.Л. |
Композиция и способ лечения hpv
|
AU2012284147A1
(en)
|
2011-07-19 |
2014-02-27 |
Stc. Unm |
Intraperitoneally-administered nanocarriers that release their therapeutic load based on the inflammatory environment of cancers
|
GB201112950D0
(en)
|
2011-07-27 |
2011-09-14 |
Sisaf Ltd |
A system and method for delivery of an active material
|
CA2865349C
(en)
|
2012-03-06 |
2021-07-06 |
Ferrosan Medical Devices A/S |
Pressurized container containing haemostatic paste
|
RU2666963C2
(ru)
|
2012-04-13 |
2018-09-13 |
Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Агрегированные частицы
|
EP2977066A3
(en)
|
2012-06-12 |
2016-07-27 |
Ferrosan Medical Devices A/S |
Dry haemostatic composition
|
WO2014059170A1
(en)
|
2012-10-10 |
2014-04-17 |
The Trustees Of Columbia University In The City Of New York |
Systems and methods for mechanical mapping of cardiac rhythm
|
AU2013352259B2
(en)
|
2012-11-29 |
2018-06-14 |
Insmed Incorporated |
Stabilized vancomycin formulations
|
US20140219926A1
(en)
*
|
2013-02-01 |
2014-08-07 |
The Trustees Of Dartmouth College |
Biodegradable Iron Oxide Nanoparticle Gel for Tumor Bed Therapy
|
US20140243712A1
(en)
*
|
2013-02-28 |
2014-08-28 |
Doheny Eye Institute |
Thrombolysis in retinal vessels with ultrasound
|
CN104043104B
(zh)
|
2013-03-15 |
2018-07-10 |
浙江创新生物有限公司 |
含盐酸万古霉素的喷雾干粉及其工业化制备方法
|
US9247921B2
(en)
|
2013-06-07 |
2016-02-02 |
The Trustees Of Columbia University In The City Of New York |
Systems and methods of high frame rate streaming for treatment monitoring
|
BR112015030612B1
(pt)
|
2013-06-21 |
2020-07-21 |
Ferrosan Medical Devices A/S |
método para preparar uma composição seca
|
US10322178B2
(en)
|
2013-08-09 |
2019-06-18 |
The Trustees Of Columbia University In The City Of New York |
Systems and methods for targeted drug delivery
|
EP3035903B1
(en)
|
2013-08-20 |
2018-08-22 |
Anutra Medical, Inc. |
Syringe fill system and method
|
US9308165B2
(en)
*
|
2013-08-22 |
2016-04-12 |
Therapeutic Vision, Inc. |
Composition for treating ocular effects of diabetes
|
US10028723B2
(en)
|
2013-09-03 |
2018-07-24 |
The Trustees Of Columbia University In The City Of New York |
Systems and methods for real-time, transcranial monitoring of blood-brain barrier opening
|
US10363324B2
(en)
*
|
2013-11-04 |
2019-07-30 |
The South African Nuclear Energy Corporation Limited |
Pharmaceutical composition
|
WO2015080901A1
(en)
|
2013-11-26 |
2015-06-04 |
Celleration Inc. |
Systems and methods for producing and delivering ultrasonic therapies for wound treatment and healing
|
US20160303242A1
(en)
|
2013-12-09 |
2016-10-20 |
Durect Corporation |
Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
|
EP3470094B1
(en)
|
2013-12-11 |
2020-07-22 |
Ferrosan Medical Devices A/S |
Dry composition comprising an extrusion enhancer
|
CA2943201A1
(en)
*
|
2014-04-08 |
2015-10-15 |
Aradigm Corporation |
Liposomes that form drug nanocrystals after freeze-thaw
|
RU2016143590A
(ru)
|
2014-04-08 |
2018-05-11 |
Арадайм Корпорейшн |
Липосомальные композиции ципрофлоксацина, обладающие активностью против нетуберкулезных микробактерий
|
US9895385B2
(en)
|
2014-05-15 |
2018-02-20 |
Insmed Incorporated |
Methods for treating pulmonary non-tuberculous mycobacterial infections
|
USD763433S1
(en)
|
2014-06-06 |
2016-08-09 |
Anutra Medical, Inc. |
Delivery system cassette
|
USD774182S1
(en)
|
2014-06-06 |
2016-12-13 |
Anutra Medical, Inc. |
Anesthetic delivery device
|
USD750768S1
(en)
|
2014-06-06 |
2016-03-01 |
Anutra Medical, Inc. |
Fluid administration syringe
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
CA2960309A1
(en)
|
2014-10-13 |
2016-04-21 |
Ferrosan Medical Devices A/S |
Dry composition for use in haemostasis and wound healing
|
RU2705905C2
(ru)
|
2014-12-24 |
2019-11-12 |
Ферросан Медикал Дивайсиз А/С |
Шприц для удерживания и смешивания первого и второго веществ
|
US9995864B2
(en)
*
|
2015-04-03 |
2018-06-12 |
Moxtek, Inc. |
Wire grid polarizer with silane protective coating
|
US10534120B2
(en)
|
2015-04-03 |
2020-01-14 |
Moxtek, Inc. |
Wire grid polarizer with protected wires
|
WO2016196851A2
(en)
|
2015-06-03 |
2016-12-08 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
CN107771093B
(zh)
|
2015-07-03 |
2021-06-15 |
弗罗桑医疗设备公司 |
用于混合两种组分和用于在存储条件下保持真空的注射器
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
WO2017100580A1
(en)
*
|
2015-12-10 |
2017-06-15 |
Aaron Seitz |
Sphingolipid coatings and process for manufacturing sphingolipid coatings effective for inhibiting biofilm formation
|
WO2017097255A1
(zh)
*
|
2015-12-11 |
2017-06-15 |
北京大学第一医院 |
一种检测h因子浓度的方法及试剂盒
|
JP6723266B2
(ja)
*
|
2015-12-25 |
2020-07-15 |
シャープ株式会社 |
蓄熱材、これを用いた冷蔵庫および保冷容器
|
KR20180126582A
(ko)
|
2016-04-01 |
2018-11-27 |
쎄러퓨틱스엠디, 인코퍼레이티드 |
스테로이드 호르몬 약제학적 조성물
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
MX2018014016A
(es)
|
2016-05-16 |
2019-08-01 |
Intarcia Therapeutics Inc |
Polipéptidos selectivos del receptor de glucagón y métodos para utilizarlos.
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
CN110225762A
(zh)
|
2017-01-03 |
2019-09-10 |
因塔西亚制药公司 |
包括glp-1受体激动剂的连续施用和药物的共同施用的方法
|
WO2019053689A1
(en)
*
|
2017-09-18 |
2019-03-21 |
Trend Innovations |
ENCAPSULATION SYSTEM FOR THE PROLONGED RELEASE OF ACTIVE AGENTS
|
WO2019118458A1
(en)
*
|
2017-12-11 |
2019-06-20 |
Respirogen, Inc. |
Devices and methods for delivery of oxygen to a wound
|
JP7460534B2
(ja)
|
2018-03-30 |
2024-04-02 |
インスメッド インコーポレイテッド |
リポソーム医薬品の連続製造方法
|
ES2968412T3
(es)
|
2018-05-09 |
2024-05-09 |
Ferrosan Medical Devices As |
Método para preparar una composición hemostática
|
CN110201194A
(zh)
*
|
2019-07-23 |
2019-09-06 |
山东百多安医疗器械有限公司 |
一种治疗动脉粥样硬化斑块的载药显影微泡及其制备方法
|
CN115666621A
(zh)
|
2020-01-13 |
2023-01-31 |
度勒科特公司 |
具有减少的杂质的持续释放药物递送系统及相关方法
|
KR20230104131A
(ko)
|
2020-09-21 |
2023-07-07 |
안타레스 팔마, 인코퍼레이티드 |
히드로코티손 인산나트륨 및 모노티오글리세롤의 수성 약학 제형
|
WO2023009457A1
(en)
*
|
2021-07-26 |
2023-02-02 |
Ahmed Suzanne |
Drug delivery platform for delivery of therapeutics and methods of use and manufacture thereof
|